湖南省2017—2018年肺癌低剂量螺旋CT筛查结果和依从性分析

doi:10.11904/j.issn.1002-3070.2022.02.001

Abstract

Abstract: Objective The of this study was to analyze the preliminary results of low-dose spiral CT(LDCT)screening for lung cancer and the influencing factors of the compliance in the Cancer Screening Program in Urban China in Hunan province from 2017 to 2018,so as to provide information for the prevention and control of lung cancer.Methods In five districts of Changsha city,all permanent residents aged 40~74 years were invited to fill in the high risk assessment questionnaire.The detected high-risk lung cancer patients received LDCT clinical screening for lung cancer.The results of high-risk lung cancer assessment and LDCT screening were analyzed,and logistic regression was used to analyze the influencing factors for the compliance rate of LDCT screening.Results A total of 74,768 people participated in the evaluation of high-risk groups in two years,and 12,789 people were evaluated as high-risk groups of lung cancer,with a high-risk rate of 17.1%;among them,6,406 people LDCT screening,with a compliance rate of 50.1%.A total of 64 participants(1.0%)suspected lung cancer were found in LDCT screening,and 268 patients(4.2%)were found to be positive pulmonary nodules.The detection rates of suspected lung cancer and positive pulmonary nodules increased significantly with the increase of age.Multivariate analysis was conducted on the research subjects participating in LDCT screening,and it was found that ten variables of age,education level,occupation,occupational exposure history,vegetable intake,indoor oil fume,regular physical exercise,recent mental depression,history of chronic respiratory diseases and family history of lung cancer were significantly associated with the LDCT screening compliance(P＜0.05).Conclusion This study found the influencing factors of LDCT screening compliance,and provided a theoretical basis for the improvement of LDCT screening compliance,and improved the effectiveness of lung cancer screening and early diagnosis and treatment programs in the future.

Key words: Lung cancer, Screening, Low-dose spiral CT, Compliance

CLC Number:

XIAO Haifan, YAN Shipeng, LI Jigang, SHI Zhaohui, ZOU Yanhua, XU Kekui, LIAO Xianzhen. Screening results and compliance analysis of low-dose spiral CT for lung cancer in Hunan from 2017 to 2018[J]. Journal of Practical Oncology, 2022, 36(2): 99-104.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/10.11904/j.issn.1002-3070.2022.02.001

http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/Y2022/V36/I2/99

References

1 Sung H,Ferlay J,Siegel RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
2 孙可欣,郑荣寿,张思维,等.2015年中国分地区恶性肿瘤发病和死亡分析[J].中国肿瘤,2019,28(1):1-11.
3 Zeng H,Chen W,Chen J,et al.Changing cancer survival in China during 2003–15:a pooled analysis of 17 population-based cancer registries[J].Lancet Glob Health,2018,6(5):555-567.
4 Chen K,Kang G,Zhao H,et al.Liquid biopsy in newly diagnosed patients with locoregional(Ⅰ-ⅢA)non-small cell lung cancer[J].Expert Rev Mol Diagn,2019,19(5):419-427.
5 de Koning HJ,van der Aalst CM,de Jong PA,et al.Reduced lung-cancer mortality with volume CT screening in a randomized trial[J].N Engl J Med,2020,382(6):503-513.
6 肖海帆,颜仕鹏,曹世钰,等.湖南省口腔癌早诊早治项目设计概要[J].实用肿瘤学杂志,2020,34(6):66-70.
7 陈万青,李霓,石菊芳,等.中国城市癌症早诊早治项目进展[J].中国肿瘤,2019,28(1):23-25.
8 肖海帆,颜仕鹏,许可葵,等.湖南省2012-2018年城市癌症早诊早治项目临床筛查结果初步分析[J].中国肿瘤,2019,28(11):807-815.
9 Guo L,Zhang S,Liu S,et al.Determinants of participation and detection rate of upper gastrointestinal cancer from population‐based screening program in China[J].Cancer Med,2019,8(16):7098-7107.
10 Chen H,Li N,Ren J,et al.Participation and yield of a population-based colorectal cancer screening programme in China[J].Gut,2019,68(8):1450-1457.
11 李辉章,杜灵彬,孙校华,等.浙江省城市居民癌症早诊早治项目筛查结果报告[J].浙江预防医学,2015,27(12):1189-1193.
12 Lopes PA,Picozzi G,Falaschi F,et al.Four-year results of low-dose CT screening and nodule management in the ITALUNG trial[J].J Thorac Oncol,2013,8(7):866-875.
13 Infante M,Cavuto S,Lutman FR,et al.Long-term follow-up Results of the DANTE Trial,a randomized study of lung lancer screening with spiral computed tomography[J].Am J Resp Crit Care 2015,191(10):1166-1175.
14 Yang W,Qian F,Teng J,et al.Community-based lung cancer screening with low-dose CT in China:results of the baseline screening[J].Lung Cancer,2018,117:20-26.
15 何美,李必波,杜佳,等.2012-2016年重庆城市癌症高危人群筛查结果分析[J].中国肿瘤 2018,27(3):198-201.
16 孙高峰,赵娥,谢惠芳,等.乌鲁木齐市2014年城市癌症早诊早治筛查效果分析[J].中国初级卫生保健,2018,32(3):57-60.
17 Paci E,Puliti D,Lopes Pegna A,et al.Mortality,survival and incidence rates in the ITALUNG randomised lung cancer screening trial[J].Thorax,2017,72(9):825-831.
18 Horeweg N,Scholten ET,de Jong PA,et al.Detection of lung cancer through low-dose CT screening(NELSON):a prespecified analysis of screening test performance and interval cancers[J].Lancet Oncol,2014,15(12):1342-1350.
19 Aberle DR,Adams AM,Berg CD,et al.Reduced lung-cancer mortality with low-dose computed tomographic screening[J].N Engl J Med,2011,365(5):395-409.

[1]	XU Huifang, LIU Yin, ZHAO Dongmei, LUO Yanlin, CHEN Peipei, GUO Zhen, JIA Manman, ZHENG Liyang, ZHANG Luyao, LI Mengjie, ZHANG Shaokai. Performance evaluation of a new domestic hybrid capture HPV detection technology for the management of ASC-US population [J]. Journal of Practical Oncology, 2022, 36(2): 133-136.
[2]	ZHANG Mengru, CAO Dedong, GE Wei. Comparison of efficacy and safety of Endostar intravenous continuous pumping and dripping combined with platinum-containing dual-drug regimen chemotherapy for the treatment of advanced non-small cell lung cancer [J]. Journal of Practical Oncology, 2022, 36(1): 20-25.
[3]	LUO Wen, JIA Li, ZHANG Jiawen, WANG Dongjie, KONG Yingjun. The effects of circRNA MYO1C on lung cancer cell autophagy and cancer stem cell differentiation [J]. Journal of Practical Oncology, 2021, 35(6): 500-505.
[4]	ZHOU Tianhong, GU Xiuying, YAO Fang, SONG Shuming. Analysis for screening results of breast cancer in Urumqi from 2014 to 2018 [J]. Journal of Practical Oncology, 2021, 35(5): 391-395.
[5]	WU Changshuai, ZHANG Baohui, GAO Zhenglian, ZHANG Xiaowang, WANG Kun. Research progress in anti-tumor effect of propofol and its molecular mechanism in lung cancer [J]. Journal of Practical Oncology, 2021, 35(5): 480-484.
[6]	WANG Ye, SHANG Naijian. Application progress of radiomics in the diagnosis and treatment of non-small cell lung cancer [J]. Journal of Practical Oncology, 2021, 35(5): 485-488.
[7]	QIN Chao, LI Jiang, ZHENG Yadi, WANG Fei, CAO Wei, XU Yongjie, YU Yiwen, ZHAO Liang, YU Xinyang, CHEN Hongda, REN Jiansong, WANG Yong, LI Jing, LI Ni, CHEN Wanqing. Analysis of screening compliance and related factors in high-risk populations of breast cancer in Chinese cities [J]. Journal of Practical Oncology, 2021, 35(4): 291-296.
[8]	TUO Jiyu, ZHANG Xia, HE Xiaomei, JIANG Wenzhen, FENG Jueping, JIN Xia, ZHANG Min, WEI Shaozhong. Analysis of the screening results of the urban cancer early diagnosis and treatment project in Hubei province from 2018 to 2019 [J]. Journal of Practical Oncology, 2021, 35(4): 297-301.
[9]	GUO Lanwei, ZHANG Shaokai, LIU Shuzheng, ZHENG Liyang, CHEN Qiong, CAO Xiaoqin, SUN Xibin, ZHANG Jiangong. Analysis of compliance with breast cancer screening and its influencing factors in urban areas of Henan province [J]. Journal of Practical Oncology, 2021, 35(4): 307-313.
[10]	REN Siying, CHEN Yang, SHI Qingping, ZHU Yunfang, WEN Hongmei. Characteristics of lung cancer incidence and mortality from 2011 to 2016 in the cancer registration areas of Yunnan province and its time trend [J]. Journal of Practical Oncology, 2021, 35(4): 332-338.
[11]	WEI Donghua, MA Yanling, ZHANG Juan, YIN Huiping, ZHANG Xiaopeng, ZHANG Yuhan, DAI Min, QIAN Liting. Analysis of lung cancer screening rate and screening results of urban residents in Hefei from 2014 to 2016 [J]. Journal of Practical Oncology, 2021, 35(3): 231-236.
[12]	WANG Junmei, PAN Huiqing, LI Jingyi, JIA Di, ZHAO Weiming, LV Changlian. The expression and clinical significance of MT2-MMP at the stage II of lung adenocarcinoma [J]. Journal of Practical Oncology, 2021, 35(3): 243-247.
[13]	YIN Lei, YANG Xudong, YANG Yue, NIU Xingjian, ZHOU Xiaoping, JI Hongfei, WANG Yiran. The clinical significance and related mechanism of neutrophil to lymphocyte ratio in the prognostic evaluation of patients with non small cell lung cancer [J]. Journal of Practical Oncology, 2021, 35(2): 117-124.
[14]	JIAO Zhiyun, DU Fang, HE Ling, YUAN Baofeng. Preliminary study of dynamic contrast-enhanced magnetic resonance imaging in mediastinal lymph node metastasis of lung cancer [J]. Journal of Practical Oncology, 2021, 35(2): 142-147.
[15]	DONG Cheng,DUAN Yong. Research progress on the mechanism and treatment of Dickkopf family protein in non-small cell lung cancer [J]. Journal of Practical Oncology, 2021, 35(1): 64-68.

Screening results and compliance analysis of low-dose spiral CT for lung cancer in Hunan from 2017 to 2018

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments